ARCHIVES

“Exciting” Developments In Diagnosis, Screening Methods Reported By Berlin As He Leaves NCI Post

This article is from The Cancer Letter archive.

Vol. 01 No. 15 | April 11, 1975

Download PDF Visit The Full Archive

Related Articles

FDA Designates Zometa For Priority Review.

November 30, 2001

NCI Contract Awards

November 1, 1996

Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin

July 27, 2012

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

December 28, 2012

Public Interest Representatives Says Clearinghouse Delayed TRIS Action; Brown Refutes Charge

March 10, 1978

HHS News: Shalala Appoints Group On Genetic Testing

June 25, 1999